Elite Pharmaceuticals Inc /NV/ SEC filings ELTP
Elite Pharmaceuticals Inc /NV/ has 1,000 filings in SEC EDGAR's recent list, going back to Apr 5, 2005. Its latest annual report, Form 10-K, was filed on Jun 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | May 11, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 23, 2020 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2020 | Apr 17, 2020 |
| DEFA14A | Additional proxy material | Oct 18, 2019 | — |
| DEF 14A | Proxy statement | Oct 10, 2019 | Dec 4, 2019 |
| PRE 14A | Preliminary proxy statement | Sep 27, 2019 | Dec 4, 2019 |
| DEFA14A | Additional proxy material | May 5, 2014 | — |
| DEF 14A | Proxy statement | Apr 3, 2014 | May 21, 2014 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2014 | Mar 17, 2014 |
| DEF 14A | Proxy statement | Aug 31, 2011 | Oct 18, 2011 |
| PRE 14A | Preliminary proxy statement | Jul 28, 2011 | Jul 28, 2011 |
| DEF 14A | Proxy statement | Sep 8, 2009 | Oct 23, 2009 |
| PRE 14A | Preliminary proxy statement | Aug 24, 2009 | Oct 23, 2009 |
| DEF 14A | Proxy statement | Nov 21, 2008 | Dec 19, 2008 |
| PRE 14A | Preliminary proxy statement | Nov 13, 2008 | Dec 19, 2008 |
| DEF 14A | Proxy statement | May 27, 2008 | Jun 26, 2008 |
| PRE 14A | Preliminary proxy statement | May 15, 2008 | Jun 26, 2008 |
| DEF 14A | Proxy statement | May 9, 2008 | Jun 10, 2008 |
| PRE 14A | Preliminary proxy statement | Apr 29, 2008 | Jun 10, 2008 |
| DEF 14A | Proxy statement | May 30, 2007 | Jun 26, 2007 |
| PRE 14A | Preliminary proxy statement | May 18, 2007 | Jun 26, 2007 |
| DEF 14A | Proxy statement | May 25, 2006 | Jun 28, 2006 |
| PRE 14A | Preliminary proxy statement | May 15, 2006 | Jun 15, 2006 |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ELTP (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NJ
- Headquarters
- Northvale, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1053369
- Former names
- ELITE PHARMACEUTICALS INC /DE/ (until Feb 8, 2012)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.